KR810000463B1 - Preparing process for benzoec amides - Google Patents

Preparing process for benzoec amides Download PDF

Info

Publication number
KR810000463B1
KR810000463B1 KR7700478A KR770000478A KR810000463B1 KR 810000463 B1 KR810000463 B1 KR 810000463B1 KR 7700478 A KR7700478 A KR 7700478A KR 770000478 A KR770000478 A KR 770000478A KR 810000463 B1 KR810000463 B1 KR 810000463B1
Authority
KR
South Korea
Prior art keywords
formula
compound
acid
methoxy
multiplet
Prior art date
Application number
KR7700478A
Other languages
Korean (ko)
Inventor
야스시 스즈끼
껭유 시바다
구니오 쯔까모또
리끼오 오오우찌
히로시 오오야브
시게루 구라따
Original Assignee
가브리엘 토마스
쏘시에떼 데 뛰드 씨엥띠휘끄 에 엥뒤스트리엘 드릴드 프랑스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가브리엘 토마스, 쏘시에떼 데 뛰드 씨엥띠휘끄 에 엥뒤스트리엘 드릴드 프랑스 filed Critical 가브리엘 토마스
Priority to KR7700478A priority Critical patent/KR810000463B1/en
Application granted granted Critical
Publication of KR810000463B1 publication Critical patent/KR810000463B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

N-substituted benzoic amides (I; A,R = C1-5 alkyl; Z = H, sulfomoyl) having good antiemetic and psychotropic action, were prepd. step by step. (1) VII and HX(X= Br, I) were reacted to give VIII. (2) VIII was treated with SOCl2 to give II, if necessary, II was converted to free base or acid addition salt.(3) II or their salt were reacted with RNH2(R = lower alkyl) at 0≰C ˜room temp. to give IV.(4) I was obtained by heating IV.

Description

치환 안식향산 아미드의 신규 제조방법New preparation method of substituted benzoic acid amide

본 발명은 치환 안식향산아미드의 신규 제조 방법에 관한 것으로, 더욱 상세히는 다음 식(I)로 표시되는 치환 안식향산아미드의 신규 제조방법에 관한 것이다.The present invention relates to a novel process for preparing substituted benzoic acid amide, and more particularly, to a novel process for preparing substituted benzoic acid amide represented by the following formula (I).

Figure kpo00001
Figure kpo00001

식중, A는 저급알킬기를 나타내고, R은 저급알킬기를 나타내며, Z는 수소원자 또는 술퍼모일기를 나타낸다.In the formula, A represents a lower alkyl group, R represents a lower alkyl group, and Z represents a hydrogen atom or sulfamoyl group.

상기 식(I)에 있어서 "저급 알킬기"는 직쇄상 또는 분기 쇄상일 수가 있고, 예컨대 메틸, 에틸, n-혹은 iso-푸로필, n-, iso-sec- 혹은 tert-부틸기 등의 1∼5개의 탄소원자를 갖는 것이 포함되며 특히 에틸기가 적합하다.In the formula (I), the "lower alkyl group" may be linear or branched, for example, 1 to 1, such as methyl, ethyl, n- or iso-furophyll, n-, iso-sec- or tert-butyl group. Included are those having five carbon atoms, in particular ethyl groups.

상기 식(I)의 치환안식향산아미드는 뛰어난 제토(制吐)작용 및 향정신(向精神) 작용을 가지며, 의약품으로서 유용한 화합물이다. 특히 다음식Substituted benzoic acid amide of formula (I) is a compound having excellent soil action and psychotropic action, and is useful as a medicine. Especially

Figure kpo00002
Figure kpo00002

로 표시되는 화합물은, "술피리드"라는 일반명으로 시상하부작용성항궤양제(視床下部作用性抗潰瘍劑)로서 실용화되어 있다.The compound represented by "Sulpyrid" is commonly used as a hypothalamic antiulcer agent.

종래부터 상기식(I)의 화합물의 제조 방법은 다수 제안되어 있다(예컨대 일본 특허공보 제44-23494호 및 49-47751호 등 참조). 그러나, 종래 제안되어 있는 방법은 합성이 곤란하고 고가의 1-저급 알킬-2-아미노메틸피로린을 원료소서 사용하지 않으면 안되었거나 혹은 번잡스러운 다수의 공정을 필요로 하는 등의 결점이 있어 공업적으로는 아직 충분한 것이라고 할 수 없는 실정이다.Conventionally, many methods for producing the compound of formula (I) have been proposed (see, for example, Japanese Patent Nos. 44-23494 and 49-47751, etc.). However, the conventionally proposed method is disadvantageous in that the synthesis is difficult and expensive 1-lower alkyl-2-aminomethylpyrroline has to be used as a raw material, or it requires a complicated and complicated process. It is still not enough.

본 발명은 이와 같은 결점을 갖지 않는 상기식(I)의 치환안식향산아미드의 신규 제조 방법을 제공하는 것으로서, 본 발명의 방법에 따르면 (a)식 (II)로 표시되는 옥사졸린유도체 또는 그 산부가염을 식(III)으로 표시되는 제1급아민의 존재하에 가열하든지, 혹은, (b) 식(IV)로 표시되는 화합물 또는 그 산부가염을 가열하는 것으로서 이루어지는 전기식(I)의 치환 안식향산아미드의 제조방법이 제공된다.The present invention provides a novel process for preparing a substituted benzoic acid amide of formula (I) which does not have such drawbacks. According to the method of the present invention, (a) an oxazoline derivative represented by formula (II) or an acid addition salt thereof (B) Preparation of substituted benzoic acid amide of formula (I) consisting of heating in the presence of a primary amine represented by formula (III), or (b) heating a compound represented by formula (IV) or an acid addition salt thereof. A method is provided.

Figure kpo00003
Figure kpo00003

식중, A 및 Z는 전기한 의미를 가지고, X는 반응성산잔기이며, R은 전기한 의미를 갖는다.Wherein A and Z have the foregoing meanings, X is the reactive acid residue and R has the foregoing meaning.

본 발명의 방법에 의하면, 전기식(II)의 화합물과 식(III)의 제1급 아민의 양자를 가열하여 반응케 하는 것이다.According to the method of the present invention, both the compound of formula (II) and the primary amine of formula (III) are heated to react.

식(II)에 있어서, X는 식(III)의 제1급 아민의 수소원자와 함께 HX로서 이탈될 수 있는 반응성 산잔기이고, 이와 같은 반응성 산잔기로서는 예컨대 할로겐 원자 특히 취소 또느 옥소원자가 유리하다.In formula (II), X is a reactive acid residue which can be released as HX together with the hydrogen atom of the primary amine of formula (III), and as such reactive acid residue, for example, a halogen atom, in particular a canceled or oxo atom, is advantageous. .

전기 식(II)의 화합물을 식(III)의 제1급아민의 존재하에 가열하면, 이 제1급아민이 식(II)의 화합물에 HX의 이탈을 수반하여 결합함과 동시에 이성화가 일어나서 목적한바 식(I)의 화합물이 생성된다.When the compound of formula (II) is heated in the presence of the primary amine of formula (III), the primary amine binds to the compound of formula (II) with the release of HX and isomerizes at the same time. One compound of formula (I) is produced.

반응은 무용매의 상태에서 시행할 수도 있지만, 일반적으로 불활성 유기 용매중, 예컨대 메틸 알코올, 에틸알코올, 이소프로필알코올, 에틸렌글리코올과 같은 알코올류 : 에틸에테르, 테트라히드로푸란과 같은 에테르류 : 초산에틸과 같은 에스테르류 : 트리에틸아민, 피리딘과 같은 유기 제3급 아민류 : 벤젠, 톨루엔과 같은 탄화수소 : 디메틸포름 아미드와 같은 아미드류 : 디클로로메탄, 클로로포름과 같은 할로겐화 탄화수소류 : 디메틸 술폭시드 등 중에서 시행하는 것이 바람직하다.The reaction may be carried out in the absence of a solvent, but generally inert organic solvents, for example, alcohols such as methyl alcohol, ethyl alcohol, isopropyl alcohol and ethylene glycol: ethers such as ethyl ether and tetrahydrofuran: acetic acid Esters such as ethyl: organic tertiary amines such as triethylamine, pyridine: hydrocarbons such as benzene, toluene: amides such as dimethylformamide: halogenated hydrocarbons such as dichloromethane, chloroform: dimethyl sulfoxide, etc. It is desirable to.

가온 온도에는 엄밀한 제한은 없으나, 적어도 60℃의 온도, 적합하기에는 80℃ 내지 반응혼합물의 환류온도의 범위인 가열온도가 유리하게 사용된다.There is no strict limitation on the heating temperature, but a heating temperature which is at least 60 ° C., suitably a heating temperature ranging from 80 ° C. to the reflux temperature of the reaction mixture is advantageously used.

식(II)의 화합물과 식(III)의 아민 양자의 사용 비율에는 특별한 제한이 없지만, 식(II)의 화합물과 식(III)의 아민 양자는 적어도 등몰량이고, 적합하기에는 식(III)의 아민의 과잉량, 통상 2∼5배 몰의 과잉량으로 사용하는 것이 유리하다. 식(III)의 아민을 대과잉으로 사용할 수도 있고, 이로 인해서 아민에 용해 및 산 결합제로서의 역할을 동시에 다하게 할 수도 있다.There is no particular restriction on the ratio of the use of both the compound of formula (II) and the amine of formula (III), but both the compound of formula (II) and the amine of formula (III) are at least equimolar amounts, and suitably It is advantageous to use an excess of amine, usually in an excess of 2 to 5 times the molar amount. The amine of formula (III) may be used in excess, thereby dissolving the amine and serving as an acid binder at the same time.

또한, 반응은 산 결합제의 존재하에 시행하여도 되며, 사용할 수 있는 산 결합제로서는, 예컨대 트리에틸아민, 피리딘, 피페라딘, 디메틸 아니린 등을 들 수 있으며, 이들 산 결합제는 통상 식(II)의 화합물에 대하여 적어도 등당량으로 바람직하게는 1∼1.5배 당량으로 사용할 수가 있다.In addition, the reaction may be carried out in the presence of an acid binder, and examples of the acid binder that can be used include triethylamine, pyridine, piperadine, dimethyl aniline, and the like, and these acid binders are usually formula (II). The compound may be used in an equivalent amount of at least 1 equivalent to 1.5 times.

반응시간은 가온온도나 사용한 식(II)의 화합물 및 식(III)의 아민의 종류 등에 의존해서 광범위로 바꿀수가 있는데, 일반적으로 전기한 가온온도에 1∼4시간 보지함으로써 반응을 종료시킬 수가 있다.The reaction time can be changed in a wide range depending on the heating temperature, the compound of the formula (II) used and the kind of the amine of the formula (III), and the like. .

상기 방법(a)에 있어서 출발원료로서 사용할 수 있는 식(II)의 화합물의 대표적인 예를 들면 다음과 같다.Representative examples of the compound of formula (II) which can be used as starting materials in the method (a) are as follows.

2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-브로모프로필)-4,5-디히드로옥사졸,2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole,

2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-옥도프로필)-4,5-디히드로옥사졸,2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-oxopropyl) -4,5-dihydrooxazole,

2-(2'-메톡시페닐)-5-(3'-브로모프로필)-4,5-디히드로옥사졸,2- (2'-methoxyphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole,

2-(2'-에톡시-5-술퍼모일페닐)-5-(3'-옥도프로필)-4,5-디히드로옥사졸,2- (2'-ethoxy-5-sulfurmoylphenyl) -5- (3'-oxodopropyl) -4,5-dihydrooxazole,

2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-클로로프로필)-4,5-디히드로옥사졸,2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-chloropropyl) -4,5-dihydrooxazole,

2-(2'-메톡시페닐)-5-(3'-옥도프로필)-4,5-디히드로옥사졸,2- (2'-methoxyphenyl) -5- (3'-oxodopropyl) -4,5-dihydrooxazole,

2-(2'-메톡시페닐)-5-(3'-클로로프로필)-4,5-디히드로옥사졸,2- (2'-methoxyphenyl) -5- (3'-chloropropyl) -4,5-dihydrooxazole,

및 상기 화합물의 산 부가염.And acid addition salts of the compounds.

이와 같은 식(II)의 화합물은 종래의 문헌 미제의 신규의 화합물이고 예컨대 다음의 합성공정에 의하여 제조할 수 있다.Such a compound of Formula (II) is a novel compound of the conventional literature, and can be produced by, for example, the following synthesis process.

Figure kpo00004
Figure kpo00004

식(V)로 표시되는 치환 안식향산 또는 그 반응성 유도체(예컨대, 산할라이드, 에스테르, 혼합산 무수물등)과 식(VI)으로 표시되는 아민 또는 그 반응성 유도체(예컨대, 이소시아네이트, 포스퍼아조화합물 등)과의 아미드화 반응은 그 자체 공지의 갖가지 방법에 따라 시행할 수가 있다(일본 특허원 제51-22246호 명세서 참조).Substituted benzoic acid represented by formula (V) or its reactive derivatives (e.g., acid halides, esters, mixed acid anhydrides, etc.) and amines represented by formula (VI) or its reactive derivatives (e.g., isocyanates, phosphorazo compounds, etc.) The amidation reaction with can be carried out according to various methods known per se (see Japanese Patent Application No. 51-22246).

예를 들면, 이 아미드화는 식(V)로 표시되는 치환 안식향산과 식(VI)으로 표시되는 아민과의 직접 축합에 의해 시행할 수 있다. 반응은 무용매의 상태에서 시행할 수도 있는데, 일반적으로 불활성 유기용매중, 예컨대 벤젠, 톨루엔, 키시렌과 같은 탄화수소 : 테트라드로푸란, 디옥산, 디메톡시에탄, 디글라임과 같은 에테르류 : 디메틸포름아미드, 디메틸아세트아미드와 같는 아미드류 : 디클로로메탄, 클로로포름과 같은 할로겐화 탄화수소 : 디메틸술폭시드 등의 안에서 시행하는 것이 바람직하다. 반응 온도 및 압력에는 특별한 제약은 없으며, 사용하는 원료물질 등에 따라 광범위하게 변화시킬 수가 있는데, 통상 반응온도는 약 0℃ 내지 반응 혼합물의 환류온도, 바람직하게는 실온 내지 200℃이고, 압력은 상압이 유리하다. 또한, 반응은 필요에 따라 축합제의 존재하에 실시할 수가 있고, 사용할 수 있는 축합제의 예로서는 루이스산, 특히 사염화규소, 트리클로로페닐시란 및 사염화티탄 등, N-에틸-N'-디에틸아미노프로필 카르보디이미드, N,N'-디시클로헥실 카르보디이미드 등 : 트리아릴포스핀과 디술피이드와의 조합 : 인바아라이트 IR-120등의 강산성 이온 수지 등을 들수 있다.For example, this amidation can be performed by direct condensation of the substituted benzoic acid represented by the formula (V) with the amine represented by the formula (VI). The reaction can also be carried out in the absence of solvents, generally in an inert organic solvent, for example hydrocarbons such as benzene, toluene and xylene: ethers such as tetradrofuran, dioxane, dimethoxyethane and diglyme: dimethylform Amides such as amide and dimethylacetamide: halogenated hydrocarbons such as dichloromethane and chloroform: dimethyl sulfoxide and the like. There are no particular restrictions on the reaction temperature and pressure, and the reaction temperature and pressure can be varied widely depending on the raw materials used. The reaction temperature is usually about 0 ° C to the reflux temperature of the reaction mixture, preferably room temperature to 200 ° C, and the pressure is normal pressure. It is advantageous. The reaction can be carried out in the presence of a condensation agent if necessary, and examples of the condensing agent that can be used include N-ethyl-N'-diethyl, such as Lewis acid, especially silicon tetrachloride, trichlorophenylsilane, and titanium tetrachloride. Aminopropyl carbodiimide, N, N'- dicyclohexyl carbodiimide, etc. Combination of a triaryl phosphine and a disulfide: Strong acidic ionic resins, such as invaarite IR-120, etc. are mentioned.

또한, 상기 아미드화는 전기 식(V)로 표시되는 치환 안식향산의 전술한 바와 같은 반응성 유도체(예컨대, 저급알킬탄산무수물, 저급알킬에스테르 등)과 전기식 (VI)로 표시되는 유리아민과의 사이에서, 혹은 전기식(V)로 표시되는 유리의 치환 안식향산과 전기식(VI)로 표시되는 아민의 전술한 바와 같은 반응성 유도체와의 사이에서 시행할 수도 있다. 본 아미드화도 역시 필요에 따라 용매를 사용하지 않고 시행할 수 있는데, 통상적으로는 상기한 바와 같은 불활성 유기용매 또는 고비점의 알코올류(예컨대 에틸렌 글리코올, 글리세린 등) 중에서 시행하는 것이 유리하다. 반응 온도 및 압력은 임계적인 것은 아닌데, 통상 반응 온도로서는, 약 -20℃ 내지 반응 혼합물의 환류 온도, 가급적 0℃ 내지 180℃ 범위가 바람직하고, 압력은 상압이 유리하다.Further, the amidation is carried out between the reactive derivative as described above of the substituted benzoic acid represented by the above formula (V) (for example, lower alkyl carbonate anhydride, lower alkyl ester, etc.) and the free amine represented by the formula (VI). Alternatively, it may be carried out between the substituted benzoic acid of the glass represented by the electric formula (V) and the reactive derivative as described above of the amine represented by the electrical formula (VI). The present amidation can also be carried out without the use of a solvent if necessary, and it is usually advantageous to carry out in the above-mentioned inert organic solvent or high boiling alcohols (for example, ethylene glycol, glycerin, etc.). The reaction temperature and pressure are not critical, but usually as the reaction temperature, the reflux temperature of the reaction mixture is preferably in the range of 0 ° C to 180 ° C, preferably at 0 ° C to 180 ° C.

이리하여 얻어지는 식(VII)의 화합물을 할로겐화수소(HX')로 처리하여, 식(VII)의 화합물의 테트라하이드로푸란 환을 가열시키므로서, 식(VIII)의 화합물로 바꿀 수가 있다.The compound of formula (VII) thus obtained can be converted to the compound of formula (VIII) by treating with hydrogen halide (HX ') to heat the tetrahydrofuran ring of the compound of formula (VII).

할로겐화수소에 의한 식(VII)의 화합물의 테트라히드로푸란 환의 개열반응은, 통상식(VII)의 화합물을 할로겐화수소의 수용액(할로겐화 수소산)에 용해하고, 실온 내지는 약간 가온(약 50℃까지)한 상태하에 보지함으로써 시행할 수가 있다. 할로겐화수소의 수용액의 농도는 가능한한 높은 편이 바람직하고, 예를 들어 취화수소산의 경우, 시판품의 농도는 약 47% 정도이므로 식(VII)의 화합물의 용해전 또는 후에 취화수소를 불어넣어 포화농도(약 66%) 부근에서 반응시키는 것이 바람직하다. 또한, 옥화 수소산을 사용하는 경우에는 50%정도의 농도인 것을 사용하는 것이 유리하다.The cleavage reaction of the tetrahydrofuran ring of the compound of formula (VII) with hydrogen halide is usually obtained by dissolving the compound of formula (VII) in an aqueous solution of hydrogen halide (hydrogen halide) and warming it to room temperature or slightly (up to about 50 ° C). This can be done by keeping under state. It is preferable that the concentration of the aqueous solution of hydrogen halide is as high as possible. For example, in the case of hydrofluoric acid, the concentration of commercially available products is about 47%, so that the hydrogen sulfide is blown before or after dissolution of the compound of formula (VII) and saturated concentration ( About 66%). In addition, when using hydrofluoric acid, it is advantageous to use about 50% of concentration.

일반적으로 취화수소산 보다도 옥화수소산이 활성이 크므로, 옥화수소산을 사용할 경우에는, 반응 온도는 30℃이하의 비교적 저온에서 시행하는 것이 바람직하고, 취화수소산을 사용하는 경우에는 50℃까지의 약간 가온한 상태하에 반응을 시행하는 것이 유리하다.In general, hydrofluoric acid is more active than hydrofluoric acid, so when using hydrofluoric acid, the reaction temperature is preferably carried out at a relatively low temperature of 30 ° C. or lower, and slightly warm to 50 ° C. when using hydrochloric acid. It is advantageous to carry out the reaction under conditions.

반응은 사용하는 온도, 할로겐화수소산의 종류 등에 따라 달라지는데, 통상은 15분∼48시간으로 종료된다.The reaction varies depending on the temperature to be used, the type of hydrofluoric acid, and the like, but usually ends in 15 minutes to 48 hours.

별법에서, 식(VII)의 화합물을 불활성 유기용매 예컨대, 에틸에테르, 디멕시에탄 등의 에테르류, 아세톤, 디에틸케톤 등의 케톤류, 초산메틸, 초산에틸 등의 유기산 에스테르등 속에 용해내지 분산시키고, 거기에 취화수소 또는 옥화수소의 가스를 불어넣든지, 또는 취화수소산 또는 옥화수소산을 첨가하는 것으로도 상기한 개열반응을 달성할 수 있다.Alternatively, the compound of formula (VII) is dissolved or dispersed in an inert organic solvent such as ethers such as ethyl ether and dimexane, ketones such as acetone and diethyl ketone, and organic acid esters such as methyl acetate and ethyl acetate. The above cleavage reaction can also be achieved by blowing a gas of hydrogen or hydrogen iodide therein, or by adding hydrogen or hydrocyanic acid.

취화수소 또는 옥화수소는 식(VII)의 화합물에 대하여, 적어도 등몰량, 적합하기에는 과잉량, 예컨대 2배 몰량 이상으로 사용할 수가 있다.Hydrogen embrittlement or hydrogen iodide may be used in an amount of at least equimolar amount, suitably in excess, such as 2 times or more, relative to the compound of formula (VII).

이리하여 얻어지는 식(VIII)의 화합물의 염화 티오닐에 의한 처리(환화반응)는, 예컨대 식(VIII)의 화합물에 무용매의 상태로 또는 바람직하게는 적당한 불활성 유기용매, 예컨대 초산에틸, 초산메틸과 같은 에스테르류 : 클로로포름, 사염화탄소, 디클로로메탄, 디클로로 에탄과 같은 할로겐화 탄화수소 : 벤젠, 톨루엔크실렌과 같은 탄화수소 : 디메틸에테르, 테트라하드로푸란, 디옥산 등의 에테르류 중에 용해한 상태에서, 약 0∼50℃간의 온도, 통상은 실온에 있어서 염화티오닐을 첨가하는 것으로서 시행된다.Treatment of the compound of formula (VIII) with thionyl chloride thus obtained (cyclization reaction) is, for example, in a solvent-free state to the compound of formula (VIII) or preferably inert organic solvent such as ethyl acetate, methyl acetate Esters such as: chloroform, carbon tetrachloride, halogenated hydrocarbons such as dichloromethane and dichloroethane: hydrocarbons such as benzene and toluene xylene: dissolved in ethers such as dimethyl ether, tetrahydrofuran and dioxane, about 0 to 50 It is carried out by adding thionyl chloride at a temperature between ° C, usually at room temperature.

염화티오닐의 사용량은 엄밀한 것은 아니고 사용하는 식(VIII)의 화합물의 종류나 반응 온도 등에 따라서 광범위하게 변동할 수가 있는데, 일반적으로 적어도 당량, 바람직하게는 1.1∼1.5배 당량의 과잉량으로 사용된다.The amount of thionyl chloride used is not exact and can vary widely depending on the type of the compound of formula (VIII), the reaction temperature, and the like, and is generally used in an excess of at least an equivalent weight, preferably 1.1 to 1.5 times the equivalent weight. .

반응은 일반적으로 15분∼1시간으로 종료된다. 반응후의 반응혼합물로 부터의 상기 식(II-a)의 화합물의 분리 및 정제는 그 자체 공지인 수단, 예컨대 여과 추출, 재결정, 크로마토그라피 등의 임의 수단으로 시행할 수 있다.The reaction generally ends in 15 minutes to 1 hour. Separation and purification of the compound of formula (II-a) from the reaction mixture after the reaction can be carried out by any means known per se, such as filtration extraction, recrystallization, chromatography, and the like.

상기의 환화반응에 있어서, 상기 식(II-a)의 화합물은 통상 염산염의 형태로 얻어진다. 따라서 유리염기가 바람직한 경우에는, 이리하여 얻어지는 염산염을 알칼리, 예컨대 중탄산나트륨, 중탄산 칼륨과 같은 약무기염기, 혹은 트리에틸아민, 피리딘과 같은 유기 제3급 아민으로 처리하므로서 용이하게 유리염기로 바꿀수가 있으며, 이렇게 하여 얻어지는 유리염기는 다시 산, 예컨대 염산, 황산, 인산과 같은 무기산 혹은 파라톨루엔술폰산으로 처리하는 것으로서 산부가염으로 변환시킬 수 있다.In the above cyclization, the compound of formula (II-a) is usually obtained in the form of hydrochloride. Therefore, if the free base is desired, the hydrochloride obtained thereby can be easily converted into a free base by treating it with an alkali such as a weak inorganic base such as sodium bicarbonate or potassium bicarbonate, or an organic tertiary amine such as triethylamine or pyridine. The free base thus obtained can be converted into an acid addition salt by treating with an acid such as hydrochloric acid, sulfuric acid, phosphoric acid, or paratoluenesulfonic acid.

전기 식(II)의 화합물은 유리염기의 형태로 사용할 수가 있고 혹은 그 산부가염의 형으로 사용할 수가 있다. 이와 같은 산부가염으로는, 예를 들어 염산, 황산, 인산, 과염소산 등의 무기산 또는 초산, 수산(蓚酸), 프로피온산, 푸말산, 파라톨루엔술폰산 등의 유기산과의 염을 들 수가 있다.The compound of formula (II) can be used in the form of a free base or in the form of its acid addition salt. As such acid addition salt, salt with inorganic acids, such as hydrochloric acid, a sulfuric acid, phosphoric acid, a perchloric acid, or organic acids, such as acetic acid, a fish acid, a propionic acid, a fumaric acid, a paratoluenesulfonic acid, is mentioned, for example.

본 발명의 방법(b)에 따르면, 전기식(IV)의 화합물이 가열이성화에 의하여, 목적하는 바 식(I)의 치환안식향산 아미드로 변환할 수 있다.According to the method (b) of the present invention, the compound of formula (IV) can be converted into the substituted benzoic acid amide of formula (I) as desired by heat isomerization.

이 가열이성화는 무용매 상태에서 시행할 수도 있는데, 통상 방법(a)에 관해 전술한 바와 같은 불활성유기용매 중에서 시행하는 것이 유리하다. 이성화의 온도는 적어도 60℃, 적합하기에는 80℃ 내지 반응혼합물의 환류온도의 범위온도로 할 수가 있다.This heat isomerization may be carried out in a solvent-free state, but it is usually advantageous to carry out in an inert organic solvent as described above with respect to the method (a). The temperature of isomerization can be at least 60 degreeC, suitably 80 degreeC-the range temperature of the reflux temperature of a reaction mixture.

본 이성화 반응은 극히 용이하게 진행되므로 특별히 이성화 촉매의 사용을 필요로 하지 않지만, 필요에 따라 통상의 이성화반응에서 흔히 사용되고 있는 촉매를 사용하여도 좋다.This isomerization reaction proceeds extremely easily, and therefore it does not require the use of an isomerization catalyst in particular, but if necessary, a catalyst commonly used in a normal isomerization reaction may be used.

상기 방법(b)에 있어서 사용하는 식(IV)의 화합물도 역시 종래의 문헌에 미재된 신규화합물이고, 이 화합물은 예를 들어, 전기 방법(a)에 있어서 출발원료로서 사용한 식(II)의 화합물을 무용매 상태에서 또는 방법(a)에 관해 전기한 불활성유기용매 중에서, 0℃ 내지 실온 범위의 저온에 있어 적어도 등몰량, 바람직하게는 2∼5배 몰량의 전기식(III)의 제1급 아민과 반응시킴으로써 용이하게 제조할 수가 있다. 이리하여 얻어지는 식(IV)의 화합물의 대표적인 예를 들면 다음과 같다.The compound of formula (IV) used in the above method (b) is also a novel compound which is not disclosed in the prior art, and this compound is, for example, of the formula (II) used as starting material in the above method (a). At least equimolar amounts, preferably 2 to 5 times the molar amount of the electrical formula (III), in a solvent-free state or in an inert organic solvent described for the method (a), at a low temperature in the range of 0 ° C to room temperature. It can be manufactured easily by reacting with an amine. Representative examples of the compound of formula (IV) thus obtained are as follows.

2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-에틸아미노프로필)-4,5-디히드로옥사졸, 2-(2'-메톡시-5'-술퍼모일페닐)-5-(2-메틸아미노프로필)-4,5-디히드로옥사졸, 2-(2'-메톡시페닐)-5-(3'-에틸아미노프로필)-4,5-디히드로옥사졸, 2-(2'-메톡시-5'-술퍼모일페닐)-5-(3-메틸아미노프로필)-4,5-디히드로옥사졸, 2-(2'-에톡시페닐)-5-(3'-에틸아미노프로필)-4,5-디히드로옥사졸. 상기 식(IV)의 화합물은 유리 염기의 형뿐만 아니라, 산 부가염의 형으로 사용할 수도 있다. 이와 같은 산 부가염의 예는 식(II)의 화합물에 관해 전술한 바 같은 것이다.2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-ethylaminopropyl) -4,5-dihydrooxazole, 2- (2'-methoxy-5'-sulfur Moylphenyl) -5- (2-methylaminopropyl) -4,5-dihydrooxazole, 2- (2'-methoxyphenyl) -5- (3'-ethylaminopropyl) -4,5-di Hydrooxazole, 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3-methylaminopropyl) -4,5-dihydrooxazole, 2- (2'-ethoxyphenyl) -5- (3'-ethylaminopropyl) -4,5-dihydrooxazole. The compound of formula (IV) can be used not only in the form of the free base but also in the form of acid addition salts. Examples of such acid addition salts are as described above with respect to the compound of formula (II).

상기 방법(a) 또는 (b)에 의해 얻어진 식(I)의 화합물의 반응 혼합물로부터의 분리 및 정제는 그 자체공지의 방법, 예컨대 여과, 추출, 재결정크로마토그라피 등의 방법에 의하여 시행할 수가 있다.Separation and purification of the compound of formula (I) obtained by the method (a) or (b) from the reaction mixture can be carried out by a method known per se, for example, by filtration, extraction, recrystallization chromatography, or the like. .

본 발명의 방법에 의하여 제공되는 식(I)의 화합물을 예시하면 다음과 같다.Illustrating the compound of formula (I) provided by the process of the invention is as follows.

N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시-5-술퍼모일안식향산아미드, N-(1'-에틸-2'-피로리디닐메틸)-2-에톡시-5-술퍼모일안식향산아미드, N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시안식향산아미드, N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시-5-술퍼모일안식향산아미드, 이리하여, 본 발명의 방법에 따르면, 우수한 제토작용, 항궤양 작용 및 향정신작용을 가지며, 의약으로서 유용한 식(I)의 치환 안식향산을, 합성이 곤란하고 고가의 반응 원료를 필요로 하지 않고, 또한 아무런 번잡스러운 제조공정을 거치지 않고, 고수율인 동시에 고순도로 제조할 수가 있다.N- (1'-ethyl-2'-pyrrolidinylmethyl) -2-methoxy-5-sulfurmoylbenzoic acid amide, N- (1'-ethyl-2'-pyrrolidinylmethyl) -2-ethoxy -5-Sulfamoyl benzoic acid amide, N- (1'-ethyl-2'-pyrrolidinylmethyl) -2-methoxybenzoic acid amide, N- (1'-ethyl-2'-pyrrolidinylmethyl) -2 -Methoxy-5-sulfurmoylbenzoic acid amide, thus, according to the method of the present invention, it is difficult to synthesize a substituted benzoic acid of formula (I), which has excellent earth action, antiulcer action and psychotropic effect, and is useful as a medicine. It can be produced with high yield and high purity without requiring any expensive and expensive reaction raw materials and without any complicated manufacturing process.

본 발명에 의해 제공되는 식(I)의 화합물은 그대로 유리염기의 형태로, 혹은 제제상 허용될 수 있는 산 부가염(예컨대 염산염, 황산염, 인산염 등)의 형으로, 제토제, 정신병치료약, 항궤양제 등의 의약의 유효성분으로서 사용할 수가 있다.Compounds of formula (I) provided by the present invention are in the form of free bases or in the form of acceptable acid addition salts (such as hydrochlorides, sulfates, phosphates, etc.), which are acceptable in the form of antacids, antipsychotics, antiulcers It can be used as an active ingredient of medicines such as drugs.

이하 실시예에 의해 본 발명을 더욱 상세히 설명하겠다.The present invention will be described in more detail with reference to the following examples.

[실시예 1]Example 1

(a-1)(a-1)

2-메톡시-5-술퍼모일안식향산, 23.1g을 트리에틸아민 14.1ml 및 디메틸포름아미드 150에 녹이고, 클로로개미산에틸 9.7ml를 냉각하에 적가한다. 2시간 동안 교반한 후, 테트라히드로 푸르푸릴아민 10.3g을 냉각하에 적가한다. 실온으로 4시간 동안 교반한 후, 감압하에 용매를 유거한다. 얻어진 잔사를 아세톤에서 재결정하고 26.2g의 N-(2'-테트라히드로푸라닐메틸)-2-메톡시-5-술퍼모일안식향산아미드가 얻어진다. 융점 201∼202℃. 모액으로 부터 다시 결정 1.8g이 얻어진다.23.1 g of 2-methoxy-5-sulfurmoyl benzoic acid is dissolved in 14.1 ml of triethylamine and 150 of dimethylformamide, and 9.7 ml of ethyl chloro formate is added dropwise under cooling. After stirring for 2 hours, 10.3 g of tetrahydrofurfurylamine is added dropwise under cooling. After stirring for 4 hours at room temperature, the solvent is distilled off under reduced pressure. The obtained residue was recrystallized from acetone to obtain 26.2 g of N- (2'-tetrahydrofuranylmethyl) -2-methoxy-5-sulfurmoylbenzoate. Melting point 201-202 degreeC. 1.8 g of crystals are obtained again from the mother liquor.

IR(KBr정제, cm-1); 3360, 3260, 3080, 1620.IR (KBr tablet, cm −1 ); 3360, 3260, 3080, 1620.

NMR(DMSO, δ); 1.8부근(4H, 다중선, 3.37(2H, 삼중선, J=6Hz), 3.8부근(3H, 다중선), 3.96(3H, 단중선, 7.25(2H, 폭넓은 단중선), 7.18(1H, 이중선, J=8.5Hz), 7.88(1H, 사중선, J=2.5 및 8.5Hz), 8.23(1H, 이중선, J=2.5Hz), 8.2부근(1H, 다중선).NMR (DMSO, δ); 1.8 (4H, multiple line, 3.37 (2H, triplet, J = 6 Hz), 3.8 (3H, multiple line), 3.96 (3H, singlet, 7.25 (2H, broad singlet), 7.18 (1H, Doublet, J = 8.5 Hz, 7.88 (1H, quartet, J = 2.5 and 8.5 Hz), 8.23 (1H, doublet, J = 2.5 Hz), near 8.2 (1H, multiplet).

(a-2)(a-2)

디에틸클로로포스파이트 3.13g의 톨루엔 50ml 용액에 테트라히드로푸르푸릴아민 2.02g 및 트리에틸아민 2.02g의 혼합물을 0℃로 적가한다. 30분 동안 교반한 후, 불용물을 여거하고, 여액에 2-메톡시-5-술퍼모일안식향산 2.31g을 가한다. 반응액을 1.5시간 가열환류한다. 냉각하고, 석출되는 결정을 여취하고 물로 씻는다. 다시 에테르로 씻고 건조하면 N-(2'-테트라히드로푸라닐메틸)-2-메톡시-5-술퍼모일안식향산아미드 2.02g이 얻어진다. 이것은 상기 (a-1)항에서 얻어진 것과 일치하였다.To a 50 ml solution of 3.13 g of diethylchlorophosphite toluene was added dropwise a mixture of 2.02 g of tetrahydrofurfurylamine and 2.02 g of triethylamine to 0 ° C. After stirring for 30 minutes, the insolubles were filtered off and 2.31 g of 2-methoxy-5-sulfurmoyl benzoic acid was added to the filtrate. The reaction solution is heated to reflux for 1.5 hours. Cool, filter the precipitated crystals and wash with water. Washing again with ether and drying gave 2.02 g of N- (2'-tetrahydrofuranylmethyl) -2-methoxy-5-sulfurmoylbenzoic acid amide. This is consistent with that obtained in (a-1) above.

(a-3)(a-3)

2-메톡시-5-술퍼모일안식향산 에틸에스테르 2.59g을 에틸렌글리코올 10ml에 열시 용해시키고, 이어서 테트라히드로푸르푸릴아민 2.2g을 가하여, 반응액을 55∼60℃로 64시간 가온한다. 반응액을 물에 붓고, 결정을 여취한다. 에테르로 세정한 후 건조하면 N-(2'-테트라히드로푸라닐 메틸)-2-메톡시-5-술퍼모일안식향산아미드 2.7g이 얻어진다. 이것은 상기 (a-1)항에서 얻어진 것과 일치하였다.2.59 g of 2-methoxy-5-sulfurmoyl benzoic acid ethyl esters are dissolved in 10 ml of ethylene glycol, when heated, and then 2.2 g of tetrahydrofurfurylamine is added, and the reaction solution is heated to 55 to 60 ° C. for 64 hours. The reaction solution is poured into water and the crystals are filtered off. After washing with ether and drying, 2.7 g of N- (2'-tetrahydrofuranyl methyl) -2-methoxy-5-sulfurmoylbenzoic acid amide is obtained. This is consistent with that obtained in (a-1) above.

(b-1)(b-1)

상기 (a-1)∼(a-3)항에서 얻어진 N-(2'-테트라히드로푸라닐메틸)-2-메톡시-5-술퍼모일 안식향산 아미드 5g을 47% 취화수소산 20ml에 녹이고 취화 수소를 통해 포화시킨다. 반응액을 40℃로 15분 동안 가온한 후, 감압으로 가능한 한 취화수소를 유거한다. 이어서 물에 붓고, 회중탄산나트륨 용액으로 중화시키고, 결정을 여과하여 N-(2'-히드록시-5'-브로모벤틸)-2-메톡시-5-술퍼모일안식향산아미드 4.9g을 얻는다. 융점 98∼99℃.5 g of N- (2'-tetrahydrofuranylmethyl) -2-methoxy-5-sulfurmoyl benzoic acid amide obtained in (a-1) to (a-3) above was dissolved in 20 ml of 47% hydrochloric acid, Saturate through. The reaction solution is warmed to 40 ° C. for 15 minutes, and then the hydrogenated hydrogen is distilled off as much as possible under reduced pressure. It is then poured into water, neutralized with sodium bicarbonate solution, and the crystals are filtered to yield 4.9 g of N- (2'-hydroxy-5'-bromobentyl) -2-methoxy-5-sulfurmoylbenzoate. Melting point 98-99 degreeC.

IR(KBr 정제 cm-1); 3500, 3400, 3320, 3140, 1620.IR (KBr tablet cm- 1 ); 3500, 3400, 3320, 3140, 1620.

NMR(DMSO, δ, 1.7부근(4H, 다중선), 3.54(2H, 삼중선, J=6Hz), 3.1∼4.1(3H, 다중선), 3.96(3H, 단중선), 7.29(1H, 이중선 J=8.5Hz), 7.27(2H, 폭넓은 단중선), 7.87(1H, 4중선, J=2.5 및 8.5Hz), 8.23(1H, 이중선, J=2.5Hz), 8.2부근(1H, 다중선).NMR (DMSO, δ, around 1.7 (4H, multiplet), 3.54 (2H, triplet, J = 6Hz), 3.1 to 4.1 (3H, multiplet), 3.96 (3H, singlet), 7.29 (1H, doublet J = 8.5 Hz), 7.27 (2H, wide midline), 7.87 (1H, quadruple, J = 2.5 and 8.5 Hz), 8.23 (1H, double, J = 2.5 Hz), near 8.2 (1H, multiline ).

(b-2)(b-2)

전기 (a-1)∼(a-3)항에서 얻은 N-(2'-테트라히드로푸라닐메틸)-2-메톡시-5-술퍼모일안식향산아미드 2.56g을 50% 옥화수소산 26ml에 녹이고 25℃로 하루밤 방치한다. 반응액을 빙수중에 붓고 초산에틸에서 추출한다. 유기층을 티오황산나트륨 용액으로 씻고, 이어서 물로 씻는다. 감압하에 용매를 유거하면 N-(2'-히드록시-5'-옥도벤틸)-2-메톡시-5-술퍼모일안식향산아미드 2.4g이 결정으로 얻어진다. 융점 87∼88℃.2.56 g of N- (2'-tetrahydrofuranylmethyl) -2-methoxy-5-sulfurmoylbenzoic acid amide obtained in (a-1) to (a-3) above was dissolved in 26 ml of 50% hydrofluoric acid and 25 Let stand overnight at ℃. The reaction solution is poured into ice water and extracted with ethyl acetate. The organic layer is washed with sodium thiosulfate solution and then with water. The solvent was distilled off under reduced pressure to obtain 2.4 g of N- (2'-hydroxy-5'-oxobentyl) -2-methoxy-5-sulfurmoylbenzoic acid amide as crystals. Melting point 87-88 degreeC.

IR(KBr 정제, cm-1); 3500부근, 3390, 3300, 3100, 1620.IR (KBr tablets, cm −1 ); Near 3500, 3390, 3300, 3100, 1620.

NMR(DMSO, δ); 1.8부근(4H, 다중선) 3.29(2H, 삼중선, J=6Hz), 3.8부근(3H, 다중선), 3.96(3H, 단중선), 7.30(1H, 이중선, J=8.5Hz), 7.26(2H, 폭넓은 단중선), 7.88(1H, 사중선, J=2.5 및 8.5Hz), 8.24(1H, 이중선, J=2.5Hz). 8.2부근(1H, 다중선).NMR (DMSO, δ); 1.8 (4H, multiple line) 3.29 (2H, triplet, J = 6Hz), 3.8 (3H, multiline), 3.96 (3H, singlet), 7.30 (1H, doublet, J = 8.5Hz), 7.26 (2H, broad singlet), 7.88 (1H, quartet, J = 2.5 and 8.5 Hz), 8.24 (1H, doublet, J = 2.5 Hz). 8.2 vicinity (1H, multiplet).

(c-1)(c-1)

전기 (b-1)항에서 얻은 N-(2'-히드록시-5'-브로모펜틸)-2-메톡시-5-술퍼모일안식향산아미드 4.9g을 초산에틸 49ml에 현탁하고, 염화티오닐 2.2g을 적가한다. 실온으로 15분 동안 교반한 후 에테르 100ml를 가하여 석출된 결정을 여취한다. 수량 4.6g, 아세톤 -메타놀 혼합용매에서 재결정하여 2-(2'-메톡시 -5'-술퍼모일페닐)-5-(3'-브로모프로필)-4,5-디히드로옥사졸 산염산염을 얻는다. 융점 177∼178℃4.9 g of N- (2'-hydroxy-5'-bromopentyl) -2-methoxy-5-sulfurmoylbenzoic acid amide obtained in the above (b-1) was suspended in 49 ml of ethyl acetate, and thionyl chloride Add dropwise 2.2g. After stirring for 15 minutes at room temperature, 100 ml of ether was added to precipitate precipitated crystals. Quantity 4.6g, 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole hydrochloride by recrystallization from acetone-methanol mixed solvent Get Melting Point 177 ~ 178 ℃

IR(KBr 정제, cm-1); 1640.IR (KBr tablets, cm −1 ); 1640.

NMR(DMSO, δ); 2.0부근(4H, 다중선), 3.63(2H, 삼중선, J=6Hz), 3.84(1H, 사중선, J=3 및 12Hz), 4.10(3H, 단중선), 4.41(1H, 사중선, J=10 및 12Hz), 5.4부근(1H, 다중선), 7.58(1H, 이중선, J=8.5Hz), 7.5부근(2H, 다중선), 7.55(1H, 의 이중선, J=8.5Hz) 8.2부근(2H, 다중선).NMR (DMSO, δ); 2.0 (4H, multiple line), 3.63 (2H, triplet, J = 6 Hz), 3.84 (1H, quartet, J = 3 and 12 Hz), 4.10 (3H, singlet), 4.41 (1H, quartet, J = 10 and 12 Hz), 5.4 (1H, multiplet), 7.58 (1H, doublet, J = 8.5Hz), 7.5 (2H, multiplet), 7.55 (1H, doublet, J = 8.5Hz) 8.2 Near (2H, multiplet).

(c-2)(c-2)

상기 (c-1)에서 얻어진 산염산을 희유산에 녹이고, 중탄산나트륨 수용액으로 중화시킨다. 석출되는 결정을 여취하고, 수세 후 건조시키면 정량적으로 2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-브로모프로필)-4,5-디히드로옥시졸이 얻어진다. 아세톤에서 재결정하면 융점 161∼162℃의 결정이 얻어진다.The acid acid obtained in the above (c-1) is dissolved in a rare oil and neutralized with an aqueous sodium bicarbonate solution. The precipitated crystals were filtered off and dried after washing with water to quantitatively obtain 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxysol. Obtained. Recrystallization from acetone gives a crystal having a melting point of 161 to 162 캜.

IR(KBr 정제, cm-1), 3280, 1645.IR (KBr tablet, cm −1 ), 3280, 1645.

NMR(DMSO, δ); 1.8부근(4H, 다중선), 3.60(2H, 삼중선 J=6Hz), 3.55(1H, 사중선, J=2.5 및 14Hz), 4.06(1H, 사중선, J=9.5 및 14Hz). 3.90(3H, 단중선), 4.74(1H, 다중선), 7.26(1H, 이중선), J=8.5Hz), 7.28(2H, 폭넓은 단중선), 7.88(1H, 사중선, J=2.5 및 8.5Hz), 8.4(1H, 이중선, J=2.5Hz).NMR (DMSO, δ); Near 1.8 (4H, multiwire), 3.60 (2H, triplet J = 6 Hz), 3.55 (1H, quartet, J = 2.5 and 14 Hz), 4.06 (1H, quartet, J = 9.5 and 14 Hz). 3.90 (3H, single line), 4.74 (1H, multiline), 7.26 (1H, double line), J = 8.5 Hz, 7.28 (2H, broad single line), 7.88 (1H, quartet, J = 2.5 and 8.5 Hz), 8.4 (1H, doublet, J = 2.5 Hz).

(c-3)(c-3)

전기 (b-2)항에서 얻은 N-(2'-히드록시-5'-옥도펜틸)-2-메톡시-5-술퍼모일안식향산아미드 2.4g을 실시예 1과 같이 염화티오닐과 반응시키고, 2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-옥도프로필)-4,5-디히드록옥사졸염산염 2.5g을 얻는다. 융점 153∼154℃.2.4 g of N- (2'-hydroxy-5'-oxodopentyl) -2-methoxy-5-sulfurmoylbenzoic acid amide obtained in the above (b-2) was reacted with thionyl chloride as in Example 1 , 2.5 g of 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-oxodopropyl) -4,5-dihydroxyxazole hydrochloride is obtained. Melting point 153-154 캜.

IR(KBr 정제, cm-1); 1650.IR (KBr tablets, cm −1 ); 1650.

NMR(DMSO, δ); 2.0부근(4H, 다중선) 3.72(2H, 삼중선, J=6Hz), 3.82(1H, 사중선, J=3.5 및 12Hz). 4.11(3H, 단중선), 4.29(1H, 사중선, J=9.2 및 12Hz), 5.45 (1H, 다중선), 7.5부근(2H, 다중선), 7.57(1H,의 이중선, J=8.5Hz), 8.2부근(2H, 다중선).NMR (DMSO, δ); 2.02 (4H, multiplet) 3.72 (2H, triplet, J = 6Hz), 3.82 (1H, quadruple, J = 3.5 and 12Hz). 4.11 (3H, singlet), 4.29 (1H, quartet, J = 9.2 and 12 Hz), 5.45 (1H, multiplet), 7.5 vicinity (2H, multiplet), 7.57 (1H, doublet, J = 8.5Hz ), 8.2 (2H, multiplet).

이 염산염에서 2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-옥도프로필)-4,5-히드로옥사졸이 얻어진다. 융점 147∼148℃.2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-oxodopropyl) -4,5-hydrooxazole is obtained from this hydrochloride. Melting point 147-148 degreeC.

IR(KBr 정제, cm-1); 3280, 1645.IR (KBr tablets, cm −1 ); 3280, 1645.

(d-1)(d-1)

전기 (c-1)항에서 얻은 2-(2'-메톡시-5'-술퍼모일페닐)-5 -(3'-브로모프로필 )-4,5-디히드로옥사졸 염산염 4.6g을 에틸아민 20ml 및 디메틸포름아미드 20ml에 녹이고, 실온으로 하루밤 방치한 후, 과잉의 에틸아민을 감압하에 유거한다. 잔액을 100℃로 2시간 동안 가온한 후, 용매를 감압하에 유거하고, 얻어지는 잔사에 물을 가하고, 암모니아수를 가하여, 약 알칼리성으로 만들어 클로로포름으로 추출한다. 수세 후 용매를 유거하면 N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시-5-술퍼모일안식향산아미드 3.33g이 결정으로 얻어진다. 융점 179∼180℃.4.6 g of 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole hydrochloride obtained in the above section (c-1) was ethyl It is dissolved in 20 ml of amine and 20 ml of dimethylformamide, and after being left at room temperature overnight, excess ethylamine is distilled off under reduced pressure. After the residue was warmed to 100 ° C. for 2 hours, the solvent was distilled off under reduced pressure, water was added to the obtained residue, ammonia water was added, the solution was made slightly alkaline, and extracted with chloroform. When the solvent was distilled off after washing with water, 3.33 g of N- (1'-ethyl-2'-pyrrolidinylmethyl) -2-methoxy-5-sulfurmoyl benzoate was obtained as crystals. Melting point 179-180 degreeC.

(d-2)(d-2)

전기 (c-2)항에서 얻은 2-(2'-메톡시-5'-술퍼모일페닐)-5- (3'-브로모프로필 )-4,5-디히드로옥사졸 2.1g을 상기 (d-1)과 동일하게 처리하여 N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시-5-술퍼모일안식향산아미드 1.4g을 얻는다. 융점 179-180℃.2.1 g of 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole obtained in the above section (c-2) was added to ( In the same manner as in d-1), 1.4 g of N- (1'-ethyl-2'-pyrrolidinylmethyl) -2-methoxy-5-sulfurmoylbenzoate was obtained. Melting point 179-180 ° C.

(d-3)(d-3)

전기 (c-3)항에서 얻은 2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-옥도프로필)-4,5-디히드로옥사졸 염산염 1g을 상기 (d-1)과 동일하게 처리하여 N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시-5-술퍼모일안식향산아미드 0.6g을 얻는다. 융점 179∼ 180℃.1 g of 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-oxopropyl) -4,5-dihydrooxazole hydrochloride obtained in the above section (c-3) was added to (d In the same manner as in -1), 0.6 g of N- (1'-ethyl-2'-pyrrolidinylmethyl) -2-methoxy-5-sulfurmoylbenzoic acid amide is obtained. Melting point 179-180 degreeC.

3.53(1H, 사중선, J=7.5 및 15Hz), 3.89(3H, 단중선), 4.04(1H, 사중선, J=9.5 및 15Hz), 4.7부근(1H, 다중선), 7.26(1H, 이중선, J=8.5Hz). 7.90(1H, 사중선, J=2.5 및 8.5Hz), 8.05(1H, 2중선, J=2.5 및 8.5Hz), 8.05(1H, 이중선, J=2.5Hz).3.53 (1H, quartet, J = 7.5 and 15 Hz), 3.89 (3H, singlet), 4.04 (1H, quartet, J = 9.5 and 15 Hz), 4.7 (1H, multiplet), 7.26 (1H, doublet , J = 8.5 Hz). 7.90 (1H, quartet, J = 2.5 and 8.5 Hz), 8.05 (1H, doublet, J = 2.5 and 8.5 Hz), 8.05 (1H, doublet, J = 2.5 Hz).

MS(m/e); 341(M+).MS (m / e); 341 (M + ).

2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-에틸아미노프로필)-4,5-디히드로옥사졸 0.1g을 이소프로필알코올 5ml과 함께 가열 환류한다. 2시간 후에 용매를 유거하여 N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시-5-술퍼모일안식향산아미드 0.1g을 얻는다. 융점 178∼179℃.0.1 g of 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-ethylaminopropyl) -4,5-dihydrooxazole is heated to reflux with 5 ml of isopropyl alcohol. After 2 hours, the solvent is distilled off to obtain 0.1 g of N- (1'-ethyl-2'-pyrrolidinylmethyl) -2-methoxy-5-sulfurmoylbenzoic acid amide. Melting point 178-179 degreeC.

[실시예 2]Example 2

실시예 1의 (c-2)항에서 얻은 2-(2'-메톡시-5-술퍼모일페닐)-5-(3'-브로모프로필)-4,5-디히드로옥사졸 0.2g을 초산에틸 4ml에 현탁시킨다. 이에 트리에틸아민 0.1ml, 에틸아민 4ml 및 초산에틸 2ml로 되는 혼합물을 적가한다. 실온으로 하루밤 방치한 후 과잉의 에틸아민 및 용매의 일부를 감압하에 유거하고 분리되는 유상물을 빼내어서 클로로포름으로 씻는다. 불용의 유상물을 박층크로마토그라피에 의하여 정제하여 2-(2'-메톡시-5'-술퍼모일페닐)-5-(3'-에틸아미노프로필)-4,5-디히드로옥사졸을 유상물로서 얻는다.0.2 g of 2- (2'-methoxy-5-sulfurmoylphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole obtained in (c-2) of Example 1 It is suspended in 4 ml of ethyl acetate. To this was added dropwise a mixture of 0.1 ml of triethylamine, 4 ml of ethylamine, and 2 ml of ethyl acetate. After overnight at room temperature, excess ethylamine and a part of the solvent were distilled off under reduced pressure, and the separated oil was taken out and washed with chloroform. Insoluble oils were purified by thin layer chromatography to obtain 2- (2'-methoxy-5'-sulfurmoylphenyl) -5- (3'-ethylaminopropyl) -4,5-dihydrooxazole as oil phase. Obtained as water

IR(유상, cm-1); 3200부근, 1640.IR (oil phase, cm −1 ); Around 3200, 1640.

NMR(DMSO, δ); 1.57(3H, 삼중선, J=7Hz), 1.6부근(4H, 다중선), 2.7부근 (4H, 다중선).NMR (DMSO, δ); 1.57 (3H, triplet, J = 7Hz), 1.6 (4H, multiplet), 2.7 (4H, multiplet).

[실시예 3]Example 3

2-메톡시안식향산 3.04g을 실시예 1의 (a-1)항에 있어서의 원료 화합물의 제법과 동일하게 반응시켜서 N-(2'-테트라히드로푸라닐메틸)-2-메톡시안식향산아미드 4.5g이 유상물로서 얻는다.3.04 g of 2-methoxybenzoic acid was reacted in the same manner as in the preparation of the raw material compound according to (a-1) of Example 1 to give N- (2'-tetrahydrofuranylmethyl) -2-methoxybenzoic acid amide 4.5 g is obtained as an oil.

IR(유상, cm-1), 3420, 1650.IR (oil phase, cm -1 ), 3420, 1650.

NMR(CDCl3, δ); 1.9부근(4H, 다중선), 3.8부근(3H, 다중선), 3.95(3H, 단중선), 6.9∼8.2(4H, 다중선), 8.2부근(1H, 다중선).NMR (CDCl 3 , δ); Near 1.9 (4H, multiple line), Near 3.8 (3H, multiple line), 3.95 (3H, single line), 6.9-8.2 (4H, multiple line), Near 8.2 (1H, multiple line).

이어서 N-(2'-테트라히드로푸라닐메틸)-2-메톡시안식향산아미드 0.2g을 실시예 1의 (b-1)항에 있어서의 원료 화합물의 제법의 경우와 동일하게 반응시키고, 반응액을 빙수중에 붓고, 초산에틸로 추출한다. 유기층을 수세한 후, 망초로 건조시킨다. 감압하에 용매를 유거하면 N-(2'-히드록시-5'-브로모펜틸)-2-메톡시안식향산아미드 0.25g이 유상물로서 얻어진다.Subsequently, 0.2 g of N- (2'-tetrahydrofuranylmethyl) -2-methoxybenzoic acid amide was reacted in the same manner as in the production method of the raw material compound in Section (b-1) of Example 1, and the reaction liquid Is poured into ice water and extracted with ethyl acetate. The organic layer is washed with water and then dried with a forget-me-not. When the solvent is distilled off under reduced pressure, 0.25 g of N- (2'-hydroxy-5'-bromopentyl) -2-methoxybenzoic acid amide is obtained as an oily substance.

IR(유상, cm-1), 3380, 1620.IR (oil phase, cm -1 ), 3380, 1620.

NMR(CDCl3, δ); 1.8부근(4H, 다중선), 3.44(2H, 삼중선, J=6Hz), 3.5부근 (2H, 다중선), 3.8부근(1H, 다중선), 3.96(3H, 단중선), 6.9∼8.2(4H, 다중선), 8.4부근(1H, 다중선).NMR (CDCl 3 , δ); 1.8 (4H, multiplet), 3.44 (2H, triplet, J = 6Hz), 3.5 (2H, multiplet), 3.8 (1H, multiplet), 3.96 (3H, singlet), 6.9 to 8.2 (4H, multiplet), around 8.4 (1H, multiplet).

이리하여 얻어진 N-(2'-히드록시-5'-브로모펜틸)-2-메톡시안식향산아미드 2.5g을 실시예 1의(c-1)항에 있어서의 원료 화합물의 제법의 경우와 동일하게 처리하여 2-(2'-메톡시페닐)-5-(3'-브로모프로필)-4,5-디히드로옥사졸 염산염 2.41g을 얻는다. 융점 148∼150℃2.5 g of N- (2'-hydroxy-5'-bromopentyl) -2-methoxybenzoic acid amide thus obtained was the same as in the manufacturing method of the raw material compound of the example (c-1). To give 2.41 g of 2- (2'-methoxyphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole hydrochloride. Melting Point 148 ~ 150 ℃

IR(KBr 정제, cm-1); 1650.IR (KBr tablets, cm −1 ); 1650.

NMR(DMSO, δ); 2.0부근(H, 다중선), 3.7부근(3H, 다중선), 4.06(3H, 단중선), 4.30(1H, 사중선, J=10 및 12Hz), 5.45(1H, 다중선), 7.0∼8.1(4H, 다중선).NMR (DMSO, δ); 2.0 (H, multiple line), 3.7 (3H, multiple line), 4.06 (3H, single line), 4.30 (1H, quartet, J = 10 and 12 Hz), 5.45 (1H, multiple line), 7.0 to 8.1 (4H, multiplet).

이 염산염으로 부터 2-(2'-메톡시페닐)-5-(3'-브로모프로필)-4,5-디히드로옥사졸이 유상물로서 얻어진다.From this hydrochloride, 2- (2'-methoxyphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole is obtained as an oil.

IR(유상, cm-1); 1650.IR (oil phase, cm −1 ); 1650.

NMR(CDCl3, δ); 2.0부근(4H, 다중선), 3.49(2H, 삼중선, J=6Hz) 3.7∼4.1 (1H, 다중선), 4.31(1H, 사중선, J=9.5 및 14Hz), 4.80(1H, 다중선), 3.98(3H, 단중선), 6.8∼7.9(4H, 다중선).NMR (CDCl 3 , δ); 2.0 (4H, multiplet), 3.49 (2H, triplet, J = 6Hz) 3.7-4.1 (1H, multiplet), 4.31 (1H, quartet, J = 9.5 and 14Hz), 4.80 (1H, multiplet ), 3.98 (3H, singlet), 6.8 to 7.9 (4H, multiplet).

2-(2'-메톡시페닐)-5-(3'-브로모프로필)-4,5-디히드로옥사졸 2.0g을 실시예 1의 (d-1)항의 경우와 동일하게 처리하여 N-(1'-에틸-2-피로리디닐메틸)-2-메톡시안식향산아미드 1.43g을 유상물로서 얻는다.2.0 g of 2- (2'-methoxyphenyl) -5- (3'-bromopropyl) -4,5-dihydrooxazole was treated in the same manner as in the case of (d-1) of Example 1 to obtain N 1.43 g of-(1'-ethyl-2-pyrrolidinylmethyl) -2-methoxybenzoic acid amide is obtained as an oil.

IR(유상, cm-1); 3400, 1650.IR (oil phase, cm −1 ); 3400, 1650.

NMR(CDCl3, δ); 1.13(3H, 삼중선, J=7Hz), 1.8부근(4H, 다중선), 3.5부근 (7H, 다중선), 3.94(3H, 단중선), 6.8∼8.3(4H, 다중선), 8.4부근(1H, 다중선).NMR (CDCl 3 , δ); 1.13 (3H, triplet, J = 7Hz), 1.8 (4H, multiple), 3.5 (7H, multiple), 3.94 (3H, singlet), 6.8-8.3 (4H, multiple), 8.4 (1H, multiplet).

[실시예 4]Example 4

N-(2'-테트라히드로푸라닐메틸)-2-메톡시안식향산아미드 0.47g을 실시예 1의 (b-1)항의 제법의 경우와 동일하게 처리함으로서 N-(2'-히드록시-5'-옥도펜틸)-2-메톡시안식향산아미드 0.59g이 유상물로서 얻어진다.0.47 g of N- (2'-tetrahydrofuranylmethyl) -2-methoxybenzoic acid amide was treated in the same manner as in the manufacturing method of (b-1) of Example 1 to obtain N- (2'-hydroxy-5 0.59 g of '-oxodopentyl) -2-methoxybenzoic acid amide is obtained as an oily substance.

IR(유상, cm-1); 3400, 1640.IR (oil phase, cm −1 ); 3400, 1640.

NMR(CDCl3, δ); 1.8부근(4H, 다중선), 3.20(2H, 3중선, J=6Hz), 3.54(2H, 사중선, J=3 및 5.5Hz), 3.8부근(1H, 다중선), 6.9∼8.2(4H, 다중선), 8.34(1H, 다중선).NMR (CDCl 3 , δ); 1.8 (4H, multiple line), 3.20 (2H, triplet, J = 6 Hz), 3.54 (2H, quartet, J = 3 and 5.5 Hz), 3.8 (1H, multiple line), 6.9-8.2 (4H) , Multiplet), 8.34 (1H, multiplet).

이어서, N-(2'-히드록시-5'-옥도펜틸)-2-메톡시안식향산아미드 0.56g을 실시예 1의 (c-1)항의 경우와 동일하게 처리함으로써 2-(2'-메톡시페닐)-5-(3'-옥도프로필)-4,5-디히드로옥사졸 염산염 0.51g이 얻어진다. 융점 142∼144℃Subsequently, 0.56 g of N- (2'-hydroxy-5'-oxodopentyl) -2-methoxybenzoic acid amide was treated in the same manner as in the case of (c-1) of Example 1 to give 2- (2'-meth 0.51 g of oxyphenyl) -5- (3'-oxopropyl) -4,5-dihydrooxazole hydrochloride is obtained. Melting Point 142 ~ 144 ℃

IR(KBr 정제, cm-1); 1650.IR (KBr tablets, cm −1 ); 1650.

이 염산염으로 부터 2-(2'-메톡시페닐)-5-(3'-옥도프로필)-4,5-디히드로옥사졸이 얻어진다.2- (2'-methoxyphenyl) -5- (3'-oxopropyl) -4,5-dihydrooxazole is obtained from this hydrochloride.

IR(유상, cm-1) 1650.IR (oil phase, cm -1 ) 1650.

NMR(CDCl3, δ); 1.9부근(4H, 다중선), 3.63(2H, 삼중선, J=6Hz), 3.7부근 (1H, 다중선), 3.92(3H, 단중선), 4.19(1H, 사중선, J=9 및 14Hz), 4.6부근(1H, 다중선), 6.8∼7.8(4H, 다중선).NMR (CDCl 3 , δ); Near 1.9 (4H, multiple), 3.63 (2H, triplet, J = 6 Hz), Near 3.7 (1H, multiple), 3.92 (3H, singlet), 4.19 (1H, quartet, J = 9 and 14 Hz ), 4.6 (1H, multiplet), 6.8-7.8 (4H, multiplet).

2-(2'-메톡시페닐)-5-(3'-옥도프로필)-4,5-디히드로옥사졸 2.0g을 실시예 1의 (d-1)항과 동일하게 처리하여 N-(1'-에틸-2'-피로리디닐메틸)-2-메톡시안식향산아미드 12.6g을 얻을 수 있다.2.0 g of 2- (2'-methoxyphenyl) -5- (3'-oxodopropyl) -4,5-dihydrooxazole was treated in the same manner as in (d-1) of Example 1 to obtain N- ( 12.6 g of 1'-ethyl-2'-pyrrolidinylmethyl) -2-methoxybenzoic acid amide can be obtained.

Claims (1)

본문에 상술한 바와 같이 일반식(VII)의 화합물을 X가 브롬 또는 요오드 원자인 할로겐화 수소 HX와 반응시켜 일반식(VIII)의 화합물을 얻고, 이 일반식 (VIII)의 화합물을 염화 티오닐로 처리한 후, 필요에 따라 얻어진 염산염을 유리염기 또는 그의 산 부가염으로 전환시키고 얻어진 일반식(II)의 옥사졸린 유도체 또는 그의 산부가염을 가열하에 일반식(III)의 제1급 아민과 반응시키거나 또는 0℃ 내지 실온에서 일반식 (III)의 제1급 아민과 반응시켜 일반식(IV)의 화합물을 얻은 후, 가열시킴을 특징으로 하는 다음 일반식(I)의 치환 안식향산 아미드의 제조방법.As described above, the compound of formula (VII) is reacted with hydrogen halide HX in which X is bromine or iodine atom to obtain a compound of formula (VIII), and the compound of formula (VIII) is converted to thionyl chloride. After treatment, if necessary, the hydrochloride obtained is converted into a free base or an acid addition salt thereof and the resulting oxazoline derivative of formula (II) or acid addition salt thereof is reacted with a primary amine of formula (III) under heating. Or reacting with a primary amine of general formula (III) at 0 ° C. to room temperature to obtain a compound of general formula (IV), and then heating the method of preparing substituted benzoic acid amide of general formula (I) .
Figure kpo00005
Figure kpo00005
식중, A는 저급 알킬기이고, Z는 수소 원자 또는 술퍼모일기이며, X는 브롬 또는 요오드 원자이고, R은 저급 알킬기이다.Wherein A is a lower alkyl group, Z is a hydrogen atom or sulfamoyl group, X is a bromine or iodine atom, and R is a lower alkyl group.
KR7700478A 1977-02-28 1977-02-28 Preparing process for benzoec amides KR810000463B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR7700478A KR810000463B1 (en) 1977-02-28 1977-02-28 Preparing process for benzoec amides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7700478A KR810000463B1 (en) 1977-02-28 1977-02-28 Preparing process for benzoec amides

Publications (1)

Publication Number Publication Date
KR810000463B1 true KR810000463B1 (en) 1981-05-09

Family

ID=19203946

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7700478A KR810000463B1 (en) 1977-02-28 1977-02-28 Preparing process for benzoec amides

Country Status (1)

Country Link
KR (1) KR810000463B1 (en)

Similar Documents

Publication Publication Date Title
KR810000463B1 (en) Preparing process for benzoec amides
JPH02215750A (en) Preparation of 2,6-dichlorophenylaminobenzeneacetic acid derivative
JPS60208957A (en) Manufacture of pyrrolidone derivative
US5461157A (en) Process for preparing pyrrolidinylacetamide derivatives
US3254094A (en) 3-imino-2, 1-benzisothiazoles
CA1047504A (en) N-(2-pyrrolidinyl alkyl) substitutes and derivatives thereof
JPS6016931B2 (en) Method for producing substituted benzoic acid amide
US3960926A (en) Process for preparing azasulfonium halide salts
FI64166B (en) NYTT FOERFARANDE OCH MELLANPROTUKT FOER FRAMSTAELLNING AV S-TRIETYLFOSFINGULD-2,3,4,6-TETRA-0-ACETYL-1-THIO-BETA-D-GLUCOPYRANOSIDE (AURANOFIN)
JPH0213671B2 (en)
CA1130305A (en) Process for the preparation of n,n'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein
KR810000454B1 (en) Preparing process for benzoic amides
KR910006126B1 (en) Preparation process of n-(3-(3-cl-pyperidynyl methyl)phenoxy)propyl)-acetoxyacetate amid
JPS6144854A (en) N-dichloroalkylbenzoic acid amide and manufacture
KR810000462B1 (en) Preparing process for novel benzoic amides
US2538139A (en) Biotin derivatives and processes of preparing the same
KR950006149B1 (en) Novel n-(2-haloalkanoyloxy)succinimide derivative and manufacturing method thereof
KR790001666B1 (en) Preparation of 9,10-ethano-9,10-dihydro anthracene derivatives
US3300496A (en) Derivatives of pyrimidine-5-carboxylic acid
KR800000431B1 (en) Preparing process for 3-isoxazolyl urea derivatives
JPS5888361A (en) 3-amino-1,4-bis(alkoxycarbonyl)maleimide compound and its preparation
KR900002050B1 (en) Process for preparing proline compounds
JPS604830B2 (en) Phenyl acetic acid derivative
KR840002267B1 (en) Process for the preparation of sulfonamide derivation
JPH0368571A (en) Production of n-substituted 2,4,6-triiminotriazine derivative

Legal Events

Date Code Title Description
FPAY Annual fee payment

Payment date: 19910508

Year of fee payment: 11

EXPY Expiration of term